Discover 1,839 paid clinical trials in Lakeland, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,839
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia
for
Healthy Participants, Dyslipidemia
Location: Inverness FL, Port Orange FL, Jacksonville FL,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70
Code: NCT06980428
Phase1, Recruiting
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
A Study of Eloralintide (LY3841136) in Participants With Different Levels of Liver Damage and in Participants With Healthy Livers.
for
Hepatic Insufficiency
Location: Orlando FL, San Antonio TX
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07401862
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Pharmacokinetic Study of Vorasidenib in Severe Hepatically Impaired and Matched-Control Participants
for
Severe Hepatic Impairment, Normal Hepatic Function
Location: Orlando FL, San Antonio TX, Chandler AZ
Sponsor: Institut de Recherches Internationales Servier (I.R.I.S.)
Sex: All
Age: 18 - 70+
Code: NCT07250633
Phase1, Recruiting
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Moderate or Severe Hepatic Impairment
for
Hepatic Insufficiency, Liver Diseases
Location: Orlando FL, San Antonio TX, Chandler AZ
Sponsor: Incyte Corporation
Sex: All
Age: 18 - 70+
Code: NCT07559474
Phase1, Recruiting
A Study to Assess the Safety and Pharmacokinetics of INCB123667 When Administered Orally to Adult Participants With Severe Renal Impairment or End Stage Renal Disease
for
Renal Impairment
Location: Orlando FL, Miami Lakes FL
Sponsor: Incyte Corporation
Sex: All
Age: 18 - 70+
Code: NCT07559396
Phase1, Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
for
Lysosomal Acid Lipase Deficiency,
Location: Orlando FL, Miramar FL, Atlanta GA, Jackson MS,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 0+
Code: NCT01633489
Recruiting
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
for
Endometrial Cancer
Location: St. Petersburg FL, Orlando FL, Fort Myers FL,